Patents by Inventor Michael Harter

Michael Harter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200069962
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Inventors: Scot Johnson, Michael Harter, Josef Victor Scheeren
  • Publication number: 20200018914
    Abstract: An optical device for illuminating the vasculature of a mammal using ultraviolet, visible, and/or infrared light is described. The optical device includes an optical fiber encased in a biocompatible sheath, and is dimensioned to lie within an intravascular catheter. When placed within a vascular space and coupled with a suitable light source the optical device illuminates the vascular space and its contents. The faces of the optical fiber are configured to optimize the capture of ultraviolet, visible, and/or infrared light from a light source without the use of active optics.
    Type: Application
    Filed: April 1, 2019
    Publication date: January 16, 2020
    Inventors: Scot Johnson, Michael Harter
  • Patent number: 10512788
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: December 24, 2019
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Patent number: 10260468
    Abstract: The present invention provides for a fuel piping arrangement in common rail type fuel supply systems, the supply system comprising at least one common rail and at least one respective injector, wherein the common rail is connected with the at least one injector directly, by means of only one joint.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: April 16, 2019
    Assignee: FPT MOTORENFORSCHUNG AG
    Inventor: Michael Harter
  • Patent number: 10261277
    Abstract: An optical device for illuminating the vasculature of a mammal using ultraviolet, visible, and/or infrared light is described. The optical device includes an optical fiber encased in a biocompatible sheath, and is dimensioned to lie within an intravascular catheter. When placed within a vascular space and coupled with a suitable light source the optical device illuminates the vascular space and its contents. The faces of the optical fiber are configured to optimize the capture of ultraviolet, visible, and/or infrared light from a light source without the use of active optics.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: April 16, 2019
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter
  • Publication number: 20180078781
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 22, 2018
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Patent number: 9827438
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 28, 2017
    Assignee: UVLRX THERAPEUTICS, INC.
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Patent number: 9814899
    Abstract: Systems and methods for illumination of a vascular space and its contents using an electromagnetic energy source that supplies a plurality of wavelengths ranging from ultraviolet to infrared are shown. Illumination can be performed using multiple wavelengths, simultaneously or sequentially, and can be performed in accordance with a protocol where an initial illumination produces an effect that is at least partially reversed by a subsequent illumination. Illumination protocols can be stored on a database and accessed via a user interface displayed on the electromagnetic energy source. The database can be used to store data related to performance of system components, and such data can be used to override or modify an illumination protocol.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 14, 2017
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter
  • Patent number: 9435386
    Abstract: A fluid friction clutch includes a drivable housing having a working chamber and a reservoir, at least one opening between the reservoir and the working chamber configured to provide fluid communication between the reservoir and the working chamber, a driven disk supported for rotation in the working chamber, and a rotor mounted in the reservoir and rotatably coupled to the driven disk for rotation about an axis of rotation, the rotor having a plurality of arms, separated by a plurality of gaps, projecting away from its axis of rotation.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: September 6, 2016
    Assignee: MAHLE International GmbH
    Inventors: Michael Harter, David McDermott
  • Publication number: 20160102641
    Abstract: The present invention provides for a fuel piping arrangement in common rail type fuel supply systems, the supply system comprising at least one common rail and at least one respective injector, wherein the common rail is connected with the at least one injector directly, by means of only one joint.
    Type: Application
    Filed: June 12, 2014
    Publication date: April 14, 2016
    Inventor: Michael Harter
  • Publication number: 20150018753
    Abstract: Systems and methods for illumination of a vascular space and its contents using an electromagnetic energy source that supplies a plurality of wavelengths ranging from ultraviolet to infrared are shown. Illumination can be performed using multiple wavelengths, simultaneously or sequentially, and can be performed in accordance with a protocol where an initial illumination produces an effect that is at least partially reversed by a subsequent illumination. Illumination protocols can be stored on a database and accessed via a user interface displayed on the electromagnetic energy source. The database can be used to store data related to performance of system components, and such data can be used to override or modify an illumination protocol.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 15, 2015
    Inventors: Scot Johnson, Michael Harter
  • Publication number: 20150011837
    Abstract: An optical device for illuminating the vasculature of a mammal using ultraviolet, visible, and/or infrared light is described. The optical device includes an optical fiber encased in a biocompatible sheath, and is dimensioned to lie within an intravascular catheter. When placed within a vascular space and coupled with a suitable light source the optical device illuminates the vascular space and its contents. The faces of the optical fiber are configured to optimize the capture of ultraviolet, visible, and/or infrared light from a light source without the use of active optics.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 8, 2015
    Inventors: Scot Johnson, Michael Harter
  • Publication number: 20150012072
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 8, 2015
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Publication number: 20110067970
    Abstract: A fluid friction clutch includes a drivable housing having a working chamber and a reservoir, at least one opening between the reservoir and the working chamber configured to provide fluid communication between the reservoir and the working chamber, a driven disk supported for rotation in the working chamber, and a rotor mounted in the reservoir and rotatably coupled to the driven disk for rotation about an axis of rotation, the rotor having a plurality of arms, separated by a plurality of gaps, projecting away from its axis of rotation.
    Type: Application
    Filed: September 24, 2009
    Publication date: March 24, 2011
    Inventors: Michael Harter, David McDermott
  • Patent number: 7705043
    Abstract: The invention relates to compounds of formula (I) and their salts and stereoisomers in which the variables are as defined in the description and claims, for producing medicaments used in the treatment of cardiovascular and other diseases. Such compounds, processes for preparing them, compositions containing them, and methods of using them are claimed.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: April 27, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Michael Harter, Michael Hahn, Josef Pernerstorfer, Stefan Weigand, Johannes-Peter Stasch, Frank Wunder
  • Publication number: 20080176898
    Abstract: The present invention relates to phenylacetamides, to a process for their preparation and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, especially of cardiovascular disorders.
    Type: Application
    Filed: April 14, 2005
    Publication date: July 24, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Michael Harter, Frank Wunder, Lars Barfacker, Gunter Karig, Walter Hubsch, Hanna Tinel, Eva-Maria Becker
  • Patent number: 7329777
    Abstract: This invention relates to methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis, comprising administering an effective amount of a compound of formula (I) in which the several variables are as defined in the specification and claims.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: February 12, 2008
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Harter, Michael Hahn, Claudia Hirth-Dietrich, Andreas Knorr, Elke Stahl, Johannes-Peter Stasch, Frank Wunder
  • Publication number: 20070287698
    Abstract: The present application relates to novel tetrahydrobenzo[d]azepin-2-one derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias.
    Type: Application
    Filed: February 1, 2005
    Publication date: December 13, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Nils Griebenow, Timo Flessner, Michael Harter, Martin Raabe, Anja Buchmuller, Hilmar Bischoff, Peter Ellinghaus, Peter Kolkhof
  • Publication number: 20070179139
    Abstract: The invention relates to compounds of formula (I) and their salts and stereoisomers in which the variables are as defined in the description and claims, for producing medicaments used in the treatment of cardiovascular and other diseases. Such compounds, processes for preparing them, compositions containing them, and methods of using them are claimed.
    Type: Application
    Filed: October 10, 2006
    Publication date: August 2, 2007
    Applicant: Bayer Aktiengesellschaft
    Inventors: Cristina Alonso-Alija, Michael Harter, Michael Hahn, Josef Pernerstorfer, Stefan Weigand, Johannes-Peter Stasch, Frank Wunder
  • Patent number: D757955
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: May 31, 2016
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter